U.S. Physical Therapy, Inc. (NYSE:USPH) released its earnings results on Thursday, June 29th. The company reported $0.51 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.49 by $0.02, Bloomberg Earnings reports. U.S. Physical Therapy had a return on equity of 12.44% and a net margin of 6.44%. The firm had revenue of $97.57 million during the quarter, compared to analysts’ expectations of $97.60 million.
U.S. Physical Therapy (NYSE USPH) traded up 0.32% on Friday, hitting $62.90. The stock had a trading volume of 40,502 shares. U.S. Physical Therapy has a one year low of $51.96 and a one year high of $78.00. The company’s 50-day moving average is $62.79 and its 200-day moving average is $66.64. The stock has a market cap of $791.16 million, a P/E ratio of 37.89 and a beta of 1.06.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 7th. Stockholders of record on Friday, June 16th were given a dividend of $0.20 per share. The ex-dividend date was Wednesday, June 14th. This represents a $0.80 annualized dividend and a dividend yield of 1.27%. U.S. Physical Therapy’s dividend payout ratio is currently 42.33%.
Several research analysts recently commented on USPH shares. Zacks Investment Research cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Wednesday, June 21st. Barrington Research raised U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 target price for the company in a research note on Monday, July 3rd. Jefferies Group LLC reissued a “hold” rating and set a $63.00 target price on shares of U.S. Physical Therapy in a research note on Friday, June 30th. Cantor Fitzgerald started coverage on U.S. Physical Therapy in a research note on Monday. They set an “overweight” rating and a $72.00 target price for the company. Finally, BidaskClub cut U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research note on Sunday, July 16th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. U.S. Physical Therapy has a consensus rating of “Hold” and a consensus target price of $68.00.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.